3//SEC Filing
Lung Therapeutics, Inc. 3
Accession 0001213900-19-021020
CIK 0001733413other
Filed
Oct 23, 8:00 PM ET
Accepted
Oct 24, 6:42 PM ET
Size
3.6 KB
Accession
0001213900-19-021020
Insider Transaction Report
Form 3
Lung Therapeutics, Inc.
10% Owner
Holdings
- 4,000,000
Common Stock
Documents
Issuer
TFF Pharmaceuticals, Inc.
CIK 0001733413
Entity typeother
IncorporatedTX
Related Parties
1- filerCIK 0001611241
Filing Metadata
- Form type
- 3
- Filed
- Oct 23, 8:00 PM ET
- Accepted
- Oct 24, 6:42 PM ET
- Size
- 3.6 KB